Close

Ocular Therapeutix (OCUL) Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessich is Stepping Down as President and CEO Apr 15, 2024 07:02AM
Ocular Therapeutix (OCUL) Announces Board and Leadership Updates Feb 22, 2024 07:32AM
Opthea (OPT) Announces Management Changes Feb 1, 2024 06:02AM
biote (BTMD) Appoints Robert Peterson as CFO Jan 11, 2024 04:05PM
Oculis Holding (OCS) Appoints Rebecca Weil as Chief Commercial Officer Sep 11, 2023 06:31AM
View Older Stories

Aug 31, 2023 05:51AM Verona Pharma plc (VRNA) Appoints Christina Ackermann to its Board
Apr 26, 2023 07:04AM Oculis (OCS) Opens New Offices in the US
Jan 12, 2023 06:45AM Mallinckrodt (MNK) Appoints Peter Richardson as Chief Scientific Officer
Dec 19, 2022 07:17AM ADC Therapeutics SA (ADCT) Appoints Jose Carmona as CFO
Aug 23, 2022 06:07AM Alcon (ALC) Acquires Aerie Pharmaceuticals (AERI) for $15.25/sh or $770M
Jun 9, 2022 07:47AM Immunocore (IMCR) Appoints Siddharth (Sid) Kaul to its Board
Apr 22, 2022 08:18AM Opthea (OPT) Appoints Quinton Oswald and Susan Orr to its Board
Apr 13, 2022 04:06PM Graybug Vision Inc. (GRAY) Appoints Dirk Sauer to its Board
Mar 1, 2022 08:04AM Inari Medical, Inc. (NARI) Appoints Robert Warner to its Board
Feb 22, 2022 05:32PM Chicos FAS (CHS) Names Nike's Eli Kumekpor to Board
Feb 16, 2022 10:15AM RBC Capital Sees Positive Read-Through to Bausch Health Companies (BHC) from Alcon's (ALC) EPS
Jan 3, 2022 06:05AM Opthea (OPT) Appoints Judith Robertson as CCO to Lead Commercialization of OPT-302 for Wet AMD
Nov 8, 2021 05:39AM Alcon (ALC) to Acquire Ivantis for $475M Upfront
Jun 28, 2021 06:30AM Ault Global Holdings (DPW) to Acquire up to 40% of Adtech Pharma, Inc.
Jun 1, 2021 07:16AM Opthea (OPT) Named Dr. Julia Haller and Ms. Judith Robertson to Board
Apr 28, 2021 05:28PM Alcon (ALC) to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza
Mar 23, 2021 08:26AM Alcon Inc. (ALC) Capital Markets Day Is Likely a Positive Catalyst - Jefferies
Mar 22, 2021 05:15AM UPDATE: BTIG Upgrades Alcon Inc. (ALC) to Buy
Dec 15, 2020 08:05AM CDK Global (CDK) Announces Eric Guerin as CFO
Sep 25, 2020 08:07AM Graybug Vision Inc. (GRAY) Adds Christina Ackermann, Eric Bjerkholt and Julie Eastland to Board
Jul 14, 2020 07:53AM Alcon (ALC) Announces FDA Approval of the OTC Switch of Pataday Once Daily Relief Extra Strength
Mar 12, 2020 07:00AM Aldeyra Therapeutics (ALDX) Announces Strategic Prioritization of Late-Stage Clinical Pipeline in Ocular Disease
Feb 25, 2020 09:53AM Edward Jones Reiterates Buy Rating on Novartis (NVS), Favors Attractive Pipeline
Nov 13, 2019 07:08AM Precision BioSciences (DTIL) Announces Kevin J. Buehler to Board
Jul 18, 2019 06:12AM Novartis (NVS) Tops Q2 EPS by 12c, Offers Outlook
Apr 10, 2019 06:57AM Berenberg Starts Alcon Inc. (ALC) at Hold
Apr 10, 2019 06:23AM Bausch Health Companies (BHC) $41 PT Reiterated At Mizuho After A Post Novartis Spin SOTP Analysis
Apr 9, 2019 09:52AM Novartis (NVS) calls active on Alcon (ALC) eye care spin-off
Apr 9, 2019 06:17AM Alcon (ALC) to Debut on NYSE Following Novartis Spin-Off
Apr 8, 2019 09:30AM Cleveland Research Starts Alcon Inc. (ALC) at Neutral
Aug 29, 2018 08:58AM Pre-Open Movers 08/29: (GKOS) (TLRY) (SPHS) (EXPR) Higher; (AEO) (DKS) (ROKU) Lower
Aug 29, 2018 07:44AM Glaukos Corporation (GKOS) Gains After Alcon (NVS) Announces Withdrawal of CyPass Micro-Stent from Market
Aug 29, 2018 01:00AM Alcon announces voluntary global market withdrawal of CyPass Micro-Stent for surgical glaucoma
Aug 20, 2018 06:30AM Aerie Pharmaceuticals Announces Appointment of Jeffrey White, Ph.D. as Director, Toxicology and Pharmacokinetics
Jul 31, 2018 04:31AM MerLion Regains North American Rights to XTOROTM FDA-Approved Antibiotic for Treatment of Ear Infections
Jul 20, 2018 09:05AM Alcon introduces NGENUITY® 3D Visualization System with DATAFUSION™ to simplify, customize vitreoretinal surgery
Jul 18, 2018 07:59AM Novartis (NVS) Tops Q2 EPS by 2c (Earlier)
Jul 18, 2018 04:20AM Novartis hints at 2018 outlook hike despite drug price freeze
Jul 18, 2018 01:00AM Novartis delivers solid growth in second quarter and continues transformation to a focused medicines company
Jul 17, 2018 08:00AM Sinovant Sciences, Company Focused on the Development of Innovative Medicines in China, Unveiled at Event in Beijing
Jun 30, 2018 05:55AM Novartis chairman says Alcon worth $20 billion-$30 billion: Finanz und Wirtschaft
Jun 29, 2018 08:44AM Novartis (NVS) to Spinoff Alcon (Earlier)
Jun 29, 2018 01:23AM Novartis hands investors Alcon spin-off, $5 billion share buyback
Jun 29, 2018 01:00AM Novartis announces intention to seek shareholder approval for 100% spinoff of Alcon eye care devices business; initiates share buyback of up to USD 5 bn
Jun 27, 2018 08:00AM uStudio Introduces First Secure Podcast Solution for Private Enterprise Communications
Jun 18, 2018 01:15AM Novartis International AG: Alcon AcrySof® IQ PanOptix® trifocal intraocular lens shows superior visual performance in head-to-head trial post-cataract surgery
May 22, 2018 11:01AM Earth Science Laboratories Expands Research and Development
May 17, 2018 08:45AM Alcon teams up with Venus Williams, tennis champion and dry eye sufferer, to launch Systane® Complete eye drops
May 16, 2018 01:23AM Novartis top lawyer exits over Trump attorney deal 'mistake'
May 16, 2018 01:15AM At the Meet Novartis Management investor event, Novartis highlights strategy to focus the company and drive sustainable growth
View Older Stories